Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT03732820 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03732820
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2021-07-30
- Enrollment
- 895
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.